These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23088957)

  • 1. Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature.
    Caffo O; Veccia A; Fellin G; Russo L; Mussari S; Galligioni E
    Crit Rev Oncol Hematol; 2013 May; 86(2):176-90. PubMed ID: 23088957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer].
    Asadauskiene J; Aleknavicius E; Zelviene TP; Jankevicius F
    Medicina (Kaunas); 2006; 42(10):781-7. PubMed ID: 17090976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined systemic therapy and radiotherapy for bladder cancer.
    Rödel C; Weiss C; Sauer R
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():29-31. PubMed ID: 18167005
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
    Caffo O; Fellin G; Graffer U; Valduga F; Bolner A; Luciani L; Tomio L; Galligioni E
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1310-6. PubMed ID: 14630267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiochemotherapeutic options for bladder cancer].
    Weiss C; Sauer R; Rödel C
    Aktuelle Urol; 2008 Mar; 39(2):123-9. PubMed ID: 18379965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concomitant chemoradiotherapy of infiltrating cancers of the bladder].
    Housset M
    Cancer Radiother; 1998 Dec; 2(6):713-7. PubMed ID: 9922778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies.
    Caffo O; Fellin G; Graffer U; Mussari S; Tomio L; Galligioni E
    Cancer; 2011 Mar; 117(6):1190-6. PubMed ID: 20960501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of bladder preservation in the treatment of muscle invasive bladder cancer.
    Kim HL; Steinberg GD
    J Urol; 2000 Sep; 164(3 Pt 1):627-32. PubMed ID: 10953112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
    Koga F; Kihara K
    Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer.
    Turgeon GA; Souhami L; Cury FL; Faria SL; Duclos M; Sturgeon J; Kassouf W
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):326-31. PubMed ID: 24411604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer.
    Kanady KE; Shipley WU; Zietman AL; Kaufman DS; Althausen AF; Heney NM
    Semin Surg Oncol; 1997; 13(5):359-64. PubMed ID: 9259092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodalities for bladder cancer in elderly: Transurethral resection, hypofractionated radiotherapy and gemcitabine.
    Mohamed HAH; Salem MA; Elnaggar MS; Gabr A; Abdelrheem AM
    Cancer Radiother; 2018 May; 22(3):236-240. PubMed ID: 29678595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.
    Asadauskiene J; Aleknavicius E; Pipiriene-Zelviene T; Jankevicius F
    Medicina (Kaunas); 2010; 46(5):305-14. PubMed ID: 20679745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation.
    Khaled HM; Shafik HE; Zabhloul MS; Ghoneim M; Saber RA; Manie M; Enein HA; Megeed HA; Mansur O; Sherbini ME; Mahran TZ; Kalawee ME; Badran A; Ramadan SM
    Clin Genitourin Cancer; 2014 Oct; 12(5):e233-40. PubMed ID: 24889794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
    Jiang DM; Chung P; Kulkarni GS; Sridhar SS
    Curr Oncol Rep; 2020 Feb; 22(2):14. PubMed ID: 32008105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
    Herman JM; Smith DC; Montie J; Hayman JA; Sullivan MA; Kent E; Griffith KA; Esper P; Sandler HM
    Urology; 2004 Jul; 64(1):69-73. PubMed ID: 15245938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
    Feneley MR; Mellon JK
    Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder-sparing approaches to invasive disease.
    Efstathiou JA; Zietman AL; Kaufman DS; Heney NM; Coen JJ; Shipley WU
    World J Urol; 2006 Nov; 24(5):517-29. PubMed ID: 17082940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.